Aterian (NASDAQ:ATER) Trading Down 4.3% – Here’s Why

Shares of Aterian, Inc. (NASDAQ:ATER) dropped 4.3% during trading on Monday . The stock traded as low as $1.32 and last traded at $1.32. Approximately 139,572 shares were traded during mid-day trading, a decline of 18% from the average session volume of 169,403 shares. The stock had previously closed at $1.38.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 19th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Aterian presently has an average rating of “Sell”.

Aterian Stock Down 4.3%

The company’s fifty day moving average is $1.06 and its two-hundred day moving average is $0.81. The stock has a market cap of $14.28 million, a price-to-earnings ratio of -0.51 and a beta of 0.71.

Aterian (NASDAQ:ATER) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.39) EPS for the quarter, topping the consensus estimate of ($0.69) by $0.30. Aterian had a negative net margin of 39.56% and a negative return on equity of 82.05%. The company had revenue of $0.02 million during the quarter, compared to analysts’ expectations of $15.82 million.

Institutional Trading of Aterian

A number of institutional investors have recently bought and sold shares of ATER. Susquehanna International Group LLP increased its holdings in shares of Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock valued at $43,000 after acquiring an additional 30,637 shares during the last quarter. Citadel Advisors LLC boosted its holdings in Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock valued at $35,000 after purchasing an additional 22,865 shares in the last quarter. XTX Topco Ltd purchased a new position in Aterian in the second quarter valued at approximately $55,000. Finally, Goldman Sachs Group Inc. raised its holdings in Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after purchasing an additional 9,026 shares in the last quarter. 7.02% of the stock is owned by hedge funds and other institutional investors.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.